20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF
#902TREATMENT OF CILIOPATHIES
#903FUSION PROTEIN NANODISK COMPOSITIONS AND METHODS OF TREATMENT
#904ENGINEERED ENDOTHELIAL CELLS EXPRESSING AN ETS TRANSCRIPTION FACTOR
#905ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS
#906TARGETING DEREGULATED WNT SIGNALING IN CANCER USING STABILIZED ALPHA-HELICES OF BCL-9
#907COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS
#908METHODS AND COMPOSITIONS FOR TRANSGENE EXPRESSION
#909Immunotherapy against several tumors including lung cancer
#910METHODS AND COMPOSITIONS FOR REPROGRAMMING MÜLLER GLIA
#911PROTEINS WITH CARDIOPROTECTIVE ACTIVITY
#912Novel Codon-Optimized CFTR MRNA
#913METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING SLIT2
#914METHODS OF TREATING A TRAUMATIC BRAIN INJURY
#915LIPOCALIN MUTEIN FOR TREATMENT OF ASTHMA
#916PHARMACEUTICAL COMPOSITION COMPRISING FRATAXIN FUSION PROTEIN AND METHODS OF USE THEREOF
#917USE OF Dvl3-DEP PEPTIDE IN PREPARATION OF MEDICAMENT FOR REPAIRING SERTOLI CELL INJURY IN TESTES
#918Method and System for Reducing the Likelihood of Developing Depression in an Individual
#919Polypeptides for treatment of cancer
#920AMPHIPHYSIN / BIN1 FOR THE TREATMENT OF AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY
#921TREATMENT OF AGING OR AGE-RELATED DISORDERS USING XBP1
#922Methods and Compositions for Treating Melanoma
#923BETA-CASEIN A2 AND REDUCING OR PREVENTING SYMPTOMS OF LACTOSE INTOLERANCE
#924METHODS AND COMPOSITIONS FOR TUSC2 IMMUNOTHERAPY
#925INHALED ADMINISTRATION OF LIPOCALIN MUTEINS
#926Combination Immunotherapy For The Treatment of Cancer
#927COMPOSITIONS COMPRISING CHOLINE
#928USE OF ANNEXIN V AS A METHOD TO BLOCK TUMOR INDUCED IMMUNOSUPPRESSION OF THE INNATE IMMUNE RESPONSE
#929TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR
#930Method of using PRD, PRD-S TAD, ZF7 peptide or mixture thereof to inhibit cellular response to inflammatory stimuli or treat cytokine-storm-mediated diseases
#931BRAIN REPAIR AFTER TRAUMATIC BRAIN INJURY THROUGH NEUROD1-MEDIATED ASTROCYTE-TO-NEURON CONVERSION
#932METHODS AND COMPOSITIONS OF CHONDRISOMES
#933TAZ ACTIVATORS AND WNT AGONISTS FOR TREATING EAR DISORDERS
#934COMPOSITIONS FOR DIAGNOSIS, PREVENTION, OR TREATMENT OF FATTY LIVER DISEASE
#935COMPOSITIONS AND METHODS FOR IN VIVO EXCISION OF HIV-1 PROVIRAL DNA
#936Dry powder inhaler and system for drug delivery
#937COMBINATION OF NASAL GENE DELIVERY AND ORAL CINNAMIC ACID, OLEAMIDE OR GEMFIBROZIL FOR LYSOSOMAL STOARGE DISORDERS
#938Irisin improves placental function during pregnancy
#939Annexin-coated particles
#940DIRECT REPROGRAMMING OF CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES USING AN ENDOTHELIAL CELL TRANSDIFFERENTIATION STRATEGY
#941Modulating Neuroinflammation
#942Compositions for treating heart disease by inhibiting the action of mAKAP-β
#943USE OF ANNEXINS IN PREVENTING AND TREATING MUSCLE MEMBRANE INJURY
#944Method for treating disease using FOXP3+CD4+ T cells
#945METHODS TO ENHANCE T CELL REGENERATION
#946METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS
#947MYC, CYCLIN T1 AND/OR CDK9 FOR USE IN THE TREATMENT OF DEGENERATIVE HEART AND CNS DISORDERS
#948Reconstituted high density lipoprotein formulation and production method thereof
#949IMMUNOPOTENTIATING OR ANTICANCER ACTIVITY-AUGMENTING COMPOSITION COMPRISING MAL-EXPRESSED STEM CELL LIKE MEMORY T CELL AS ACTIVE INGREDIENT
#950MODULATION OF CILIOGENESIS
#951ANTI-ARRHYTHMICITY AGENTS
#952COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE
#953METHOD FOR TREATING AND/OR PREVENTING REGNASE-1-RELATED DISEASE
#954Method for preparing a bone protein preparation and a bone protein preparation
#955ALBUMIN-BOUND COMPOSITION INCLUDING LRRD2 OF SLIT3 PROTEIN FOR PREVENTION OR TREATMENT OF BONE-RELATED DISEASES
#956COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING INFLAMMATION BY INHIBITING CASPASE-9
#957METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS
#958Modulation of proprotein convertase subtilisin/kexin 9 expression (PCSK9) with HSP 27 and/or HSP25
#959COMPOSITION AND METHODS FOR MODULATION OF ELOVL2
#960HYALURONIC ACID STABILIZER
#961Method and System to Improve the Health of a Person's Skin Microbiome
#962COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#963Neuroprotective peptides
#964COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS
#965USE OF PROTEIN-BASED LONG-ACTING PREPARATION IN IMPROVING SEXUAL DYSFUNCTION
#966Composition for and Method of Treating Hepatic Tissue Injury
#967ASARM TREATMENT FOR KIDNEY AND MINERALIZATION DISORDERS AND HYPERPHOSPHATEMIA
#968MODULATION OF LC3-ASSOCIATED ENDOCYTOSIS PATHWAY AND GENETICALLY MODIFIED NON-HUMAN ANIMALS AS A MODEL OF NEUROINFLAMMATION AND NEURODEGENERATION
#969NEUROD1 COMBINATION VECTOR
#970PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS
#971Selective recovery
#972STRUCTURED GELS
#973CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF)
#974METHODS AND COMPOSITIONS RELATING TO MESENCHYMAL STEM CELL EXOSOMES
#975ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF
#976TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS
#977ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM
#978Nanoliposome Compositions And Methods Of Treating Stroke
#979TARGETING THE BAG FAMILY FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE
#980PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 GENE OR PROTEIN AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF K-RAS MUTANT LUNG CANCER
#981Pharmaceutical composition comprising PIBF protein as active ingredient for prevention or treatment of inflammatory disease
#982COMPOSITIONS AND METHODS FOR TREATING NECROTIZING ENTEROCOLITIS
#983METHODS OF TREATING NEURODEGENERATIVE DISEASES BY TARGETING THE PURINERGIC AND/OR ADENOSINE RECEPTORS
#984Compositions comprising an urolithin compound
#985ISL1-BASED GENE THERAPY TO TREAT HEARING LOSS
#986REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF DISEASE AND INJURY IN THE NERVOUS SYSTEM
#987Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
#988WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA
#989METHODS AND COMPOSITIONS FOR TREATING SKIN DISEASES
#990CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF MUSCULAR DYSTROPHY
#991PEG lipidoid compounds
#992DRINKABLE INFANT COMPOSITIONS
#993Star Polypeptides
#994Immunotherapy against several tumors including lung cancer
#995TUMOR TARGETING VITAMIN B12 DERIVATIVES FOR X-RAY ACTIVATED CHEMOTHERAPY
#996METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES USING FNDC5
#997METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION
#998Methods of treating or inhibiting onset of Huntington's disease
#999COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES
#1000USE OF GLUCOCORTICOID STEROIDS IN PREVENTING AND TREATING CONDITIONS OF MUSCLE WASTING, AGING AND METABOLIC DISORDER
#1001PEPTIDE DIRECTED PROTEIN KNOCKDOWN
#1002Gene therapy for retinitis pigmentosa
#1003APPLICATION OF ECM1 IN PREVENTION AND/OR TREATMENT OF LIVER FIBROSIS-RELATED DISEASES
#1004GLIAL FIBRILLARY ACIDIC PROTEIN TARGETING IMMUNO- AND APTAMER-BASED-THERAPY FOR NEUROINJURY, NEURODEGENERATION, NEURO-DISEASE, AND NEURO-REPAIR
#1005USE OF SAP FOR THE TREATMENT OF EUROTIOMYCETES FUNGI INFECTIONS
#1006Compositions and methods of use for secretoglobins to protect the glycocalyx via interactions with heparan sulfate proteoglycan proteins
#1007DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY
#1008COMPOSITIONS AND METHODS INVOLVING LAYILIN
#1009Method of treating osteoarthritis
#1010MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE
#1011ACTRIIB PROTEINS AND VARIANTS AND USES THEREFORE RELATING TO UTROPHIN INDUCTION FOR MUSCULAR DYSTROPHY THERAPY
#1012Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1013GASTRO-RESISTANT MICROENCAPSULATES, AND USES THEREOF TO STIMULATE IN-VIVO ILEAL GLP-1 RELEASE IN A MAMMAL
#1014METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING ATHEROSCLEROSIS AND RELATED DISEASES
#1015Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection
#1016Therapeutic method of treatment for inhibiting tumor development using Tamm-Horsfall glycoprotein (THP) as immunostimulating drug and compositions
#1017Therapeutic agent of uremia containing alarin as the main ingredient
#1018Marker for diagnosing atherosclerosis severity, and diagnostic method using same
#1019Inhibition of cytokine-induced SH2 protein in NK cells
#1020Inhibition of cytokine-induced SH2 protein in NK cells
#1021Erythropoietin Analogs For Veterinary Use
#1022Pharmaceutical compositions and methods targeting Wnt pathway proteins
#1023VDAC INHIBITORS FOR TREATING INFLAMMATORY BOWEL DISEASES
#1024VDAC INHIBITORS FOR TREATING AUTOIMMUNE DISEASES
#1025Compositions and methods for inhibiting intercellular interactions
#1026Therapeutic and diagnostic methods and compositions for neurodegenerative diseases
#1027Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1028Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1029Isoform Nell-1 peptide
#1030METHODS OF OVERCOMING RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS
#1031Native whey protein for improving intestinal maturation
#1032COMPOSITIONS AND METHODS FOR PREVENTION AND REDUCTION OF METASTASIS
#1033POWDERS CONTAINING A BUFFER SALT AND AN AMINO ACID, RECONSTITUTION OF SUCH A POWDER INTO A NUTRITIONAL PRODUCT, AND METHODS OF USING SUCH A NUTRITIONAL PRODUCT
#1034METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND IDENTIFYING TARGETS THEREFORE
#1035Inhibitors of neuroligin 4-neurexin 1-beta protein-protein interaction for treatment of liver disorders
#1036PROTEIN-BASED THERAPY AND DIAGNOSIS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER'S DISEASE
#1037Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated Diseases
#1038FUSOSOME COMPOSITIONS FOR CNS DELIVERY
#1039NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER
#1040MYB-RELATED TRANSCRIPTION FACTOR (MYPOP) AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR TUMOR THERAPY
#1041Dairy product and process
#1042TMEM100 PEPTIDES AND VARIANTS THEREOF AND THEIR USE IN TREATING OR PREVENTING DISEASES OR CONDITIONS
#1043MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE
#1044METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION WITH IMPROVED YIELD
#1045Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor
#1046Treatment of age-related macular degeneration
#1047METHODS AND MATERIALS FOR TREATING CANCER
#1048METHODS AND COMPOSITIONS COMPRISING TAU OLIGOMERS
#1049COMPOSITIONS AND METHODS FOR TREATING FRONTOTEMPORAL DEMENTIA
#1050FACTORS AND CELLS THAT PROVIDE FOR INDUCTION OF BONE, BONE MARROW, AND CARTILAGE
#1051OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR
#1052Compositions of Phosphorylated Tau Peptides and Uses Thereof
#1053THERAPEUTIC AGENT FOR CARTILAGE DISORDER
#1054Anticancer pharmaceutical composition containing IF1 as active ingredient
#1055Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders
#1056Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
#1057USE OF A SMALL NATIVE PEPTIDE ACTIVATOR OF SERCA PUMP FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS CHARACTERIZED BY CYTOSOLIC CALCIUM OVERLOAD
#1058Use of cell membrane-bound signaling factors
#1059REGULATING MUSCLE PHYSIOLOGY AND ENERGY METABOLISM USING CRYM
#1060METHOD AND SYSTEM FOR TREATING CANCER UTILIZING TINAGL1
#1061METHOD TO RESTORE OR IMPROVE COGNITIVE FUNCTIONS
#1062Therapeutic treatment of skin disease with recombinant commensal skin microorganisms
#1063Compositions and methods for treating central nervous system injury
#1064Self-replicating cell selective gene delivery compositions, methods, and uses thereof
#1065METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE
#1066Compositions and methods for treating non-age-associated hearing impairment in a human subject
#1067Modification and compositions of human secretoglobin proteins
#1068COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE CONTRACTURES
#1069Therapeutic and diagnostic methods relating to cancer stem cells
#1070ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS
#1071Methods and compositions for regenerating tissues
#1072Lipid nanoparticle formulations for delivery of MRNA
#1073METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#1074Process of manufacture of annexin V
#1075Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1076Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1077METHOD FOR MODULATING APPETITE
#1078CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS METABOLISM MOLECULES MODULATING INTRACELLULAR LACTATE CONCENTRATIONS AND THERAPEUTIC USES THEREOF
#1079INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
#1080METHODS FOR TREATMENT OF MICROBIAL DISORDERS
#1081PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION
#1082PRG-4 FOR TREATING GOUT AND ITS SYMPTOMS
#1083METHOD FOR TREATING RETINAL DEGENERATION DISEASE BY ADMINISTERING NUCLEOLIN POLYNUCLEOTIDE OR POLYPEPTIDE
#1084FUSED IN SARCOMA (FUS) NUCLEAR TRANSLOCATION INHIBITORS FOR PREVENTING FIBROSIS
#1085TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY
#1086Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1087PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 PROTEIN AND CDK4 INHIBITOR OR mTOR INHIBITOR COTREATMENT FOR PREVENTION OR TREATMENT OF CANCER
#1088Runx3 modified protein for prevention or treatment of cancer
#1089NANOPARTICLE COMPOSITIONS FOR EFFICIENT NUCLEIC ACID DELIVERY AND METHODS OF MAKING AND USING THE SAME
#1090ApoC-II mimetic peptides
#1091MODULATING IMMUNE RESPONSES
#1092Cell-penetrating cereblon recombinant fusion protein and use thereof
#1093METHODS FOR TREATING FIBROTIC CANCERS
#1094Use Of Liposomes To Deliver A Protein And A Gene Encoding The Protein To A Live Cell
#1095RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#1096Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein
#1097COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES
#1098GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#1099Prevention and treatment of viral infection and viral infection-induced organ failure
#1100STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS
#1101NANOLIPOSOME COMPOSITIONS AND METHODS OF USING THE SAME
#1102Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
#1103Uterine cancer treatments
#1104Methods and compositions for treating diabetes, and methods for enriching MRNA coding for secreted proteins
#1105METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES
#1106FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS
#1107Osteogenic biomaterial
#1108Delivery of NRF2 as therapy for protection against reactive oxygen species
#1109Uterine cancer treatments
#1110IL-10 INHIBITION FOR VACCINES AND IMMUNOTHERAPY
#1111Use of Exosome-Based Delivery of NF-KB Inhibitors
#1112Use of PRG4 as an anti-inflammatory agent
#1113Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of apoptosis
#1114Stabilized BCL9 peptides for treatment of aberrant WNT signaling
#1115Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#1116Pathways to Generate Hair Cells
#1117TREATMENT OF INFLAMMATORY CONDITIONS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN
#1118IMMUNOTOLERANCE WITH HEAT SHOCK PROTEINS
#1119Method for treating an individual suffering from a chronic infectious disease and cancer
#1120TARGETED THERAPY FOR SMALL CELL LUNG CANCER
#1121Methods and compositions for inhibiting oxidative stress
#1122Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof
#1123Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1124METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS
#1125Method for treating kidney disorders
#1126Anticancer composition comprising cervical cancer-derived autocrine motility factor as effective component
#1127INACTIVATION OF DNA REPAIR AS AN ANTICANCER THERAPY
#1128Methods for diagnosis and treatment of type 1 diabetes
#1129Anti-TrkB agonist antibodies binding to D1 domain of TrkB
#1130TREATING SPINAL CORD INJURY (SCI) AND BRAIN INJURY USING GSX1
#1131Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1132GENERATING GABAergic NEURONS IN BRAINS
#1133AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY
#1134Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1135TRANSCRIPTION FACTOR-BASED GENERATION OF PACEMAKER CELLS AND METHODS OF USING SAME
#1136PROPHYLACTIC USES OF PARTIALLY OR FULLY REDUCED FORMS OF HMGB1 PRIOR TO INJURY
#1137NOVEL METHODS FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
#1138GLUCOCEREBROSIDE TREATMENT OF DISEASE
#1139COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS
#1140Immunotherapy against several tumors including lung cancer
#1141METHODS OF TREATING CANCER USING COMBINATION THERAPY
#1142Method of managing joint pain
#1143METHODS FOR TREATING PEMPHIGUS DISORDERS
#1144Method of managing joint pain
#1145COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#1146Compositions and methods for treating cancer
#1147Intrathecal delivery of recombinant adeno-associated virus 9
#1148WHEY PROTEIN CONCENTRATE IN ASSOCIATION WITH ANTITUMOUR TREATMENT
#1149Methods of immunotherapy
#1150Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents
#1151INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9
#1152Compositions and Methods Relating to p62 for the Treatment and Prophylaxis of Age-Related Macular Degeneration
#1153AMINO ACID COMPOSITION FOR ENABLING FULFILMENT OF THE AMINO ACID REQUIREMENTS OF A MONOGASTRIC ANIMAL SUCH AS A HUMAN OR A PIG
#1154Treatment and diagnosis of melanoma
#1155ALZHEIMER'S DISEASE TREATMENT METHOD
#1156Carrier composition for eye drops and pharmaceutical composition including the same
#1157Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#1158METHOD FOR THE TREATMENT OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN NEWBORNS
#1159Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells
#1160SUMO AND USES THEREOF
#1161GLYPISOME AS AN ENHANCER OF ANGIOGENIC GROWTH FACTOR ACTIVITY
#1162THERAPEUTIC USE OF VEGF-C AND CCBE1
#1163TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA
#1164AGENT FOR ENHANCING PHAGOCYTOSIS ABILITY OF NEUTROPHILS
#1165PHARMACEUTICAL COMPOSITION FOR TREATING CARTILAGE DAMAGE, COMPRISING NASAL SEPTUM CHONDROCYTES
#1166COMPOSITIONS AND METHODS FOR TREATING OCULAR INFLAMMATION AND OCULAR SCARRING
#1167CNS delivery of mRNA and uses thereof
#1168COMPOSITIONS AND METHODS FOR GENE DELIVERY TO THE AIRWAYS AND/OR LUNGS
#1169IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
#1170METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING SICKLE-CELL DISEASE
#1171HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE
#1172Platinum compounds for binding guanine quadruplexes
#1173MESSENGER RNA THERAPY FOR THE TREATMENT OF FRIEDREICH'S ATAXIA
#1174DOMINANT NEGATIVE SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS
#1175Lipopolysaccharide-binding protein for use in a method of treating alzheimer's disease
#1176Processes for making and using a mesenchymal stem cell derived secretome
#1177HEAT SHOCK PROTEINS AND CHOLESTEROL HOMEOSTASIS
#1178OTIC FORMULATIONS FOR DRUG-INDUCED OTOTOXICITY
#1179Autoantibodies to Septin-7 and diagnosis of neurological disease
#1180STRUCTURE, MANUFACTURING AND USES OF HUMAN-DERIVED CELL-PERMEABLE PEPTIDES CONJUGATED WITH SPECIFIC BIOLOGICALLY ACTIVE CARGO PEPTIDES
#1181RECOMBINANT AAVS HAVING USEFUL TRANSCYTOSIS PROPERTIES
#1182Compositions and methods for using the CD2-based signaling pathways to block HIV infection
#1183IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
#1184POLYPEPTIDE, DERIVATIVES THEREOF, AND APPLICATION THEREOF IN PREPARATION OF DRUGS HAVING RESISTANCE TO PULMONARY FIBROSIS
#1185Frataxin expression constructs
#1186ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT
#1187Methods for treatment of Duchenne muscular dystrophy with follistatin polypeptides
#1188Inhibition of cytokine-induced SH2 protein in NK cells
#1189XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE PEPTIDES, AND METHODS OF USING SUCH PEPTIDES AND COMPOSITIONS
#1190Alterations in Endothelin Receptors Following Hemorrhage and Resuscitation by Centhaquin
#1191Human milk fortifier composition
#1192Inhibitor of IGFBP3/TMEM219 Axis and Diabetes
#1193Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#1194METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
#1195DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS
#1196Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#1197Immunotherapy against several tumors including gastrointestinal and gastric cancer
#1198COMBINATION THERAPY USING A PEPTIDE
#1199TREATMENT OF CANCER BY ACTIVATING ENDOGENOUS CRYPTIC AMYLOIDOGENIC AGGREGATING PEPTIDES
#1200Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancer